NSMCE2 and hepatocellular carcinoma: Among the genes affected by TET1-mediated changes in methylation status, several notable ones include HMGN1, NSMCE2, UIMC1, RFC2 and HMGA2, most affect the proliferation of HCC cells under sorafenib treatment (Fig S10).